Journal Article Randomized Controlled Trial Ppublish 7 citations
PubMed: 33926835 DOI: 10.1016/j.carrev.2021.04.001
Distal Versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention: Design and Rationale of the DIPRA Trial.
Cardiovasc Revasc Med 35:104-109
Authors: Karim M Al-Azizi, Amr Idris, Jared Christensen, Mohanad Hamandi, Sarah Hale, Katalin Martits-Chalangari, Johanna S Van Zyl, Preethi Ravindranathan, Jasjit K Banwait, Julie Mcckracken, Adam Smith, Ginika Apakama, Jennifer Swim, Penni Dolton, Kristen Chionh, Michael Dimaio, Sibi Thomas, Molly Szerlip, Sameh Sayfo, Chadi Dib, Michael Mack, Srinivasa Potluri
Affiliations
- Interventional Cardiology and Structural Heart Disease, Texas A&M University College of Medicine, The Heart Hospital - Plano, Baylor Scott & White Health, 1100 Allied Dr, Plano, TX 75093, United States of America.
- The Heart Hospital Plano - Baylor Scott & White, United States of America.
- Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.
- Interventional Cardiology and Structural Heart Disease, The Heart Hospital - Plano, Baylor Scott & White Health, United States of America.
- Interventional Cardiology, The Heart Hospital - Plano, Baylor Scott & White Health, United States of America.
Abstract
BACKGROUND
Radial artery (RA) catheterization is the access of choice over femoral artery access for most interventional vascular procedures given its safety and faster patient recovery. There has been growing interest in distal radial artery (dRA) access as an alternative to the conventional proximal radial artery (pRA) access. Preserving the RA is important which serves as a potential conduit for future coronary artery bypass surgery, dialysis conduit or preserve the artery for future cardiovascular procedures. The dRA runs in close proximity to the radial nerve, which raises the concern of potential detrimental effects on hand function.
STUDY DESIGN
The Distal versus Proximal Radial Artery Access for cardiac catheterization and intervention (DIPRA) trial is a prospective, randomized, parallel-controlled, open-label, single center study evaluating the outcomes of hand function and effectiveness of dRA compared to pRA access in patients undergoing cardiac catheterization. The eligible subjects will be randomized to dRA and pRA access in a (1:1) fashion. The primary end point is an evaluation of hand function at one and twelve months follow-up. Secondary end points include rates of access site hematoma, access site bleeding, other vascular access complications, arterial access success rate, and RA occlusion at one and twelve months follow up.
CONCLUSION
Effects of dRA on hand function remains unknown and it's use questionable in the presence of a widely accepted pRA. DIPRA trial is designed to determine the safety and effectiveness of dRA for diagnostic and interventional cardiovascular procedures compared to the standard of care pRA.
MeSH
Cardiac Catheterization, Arteries, Coronary Artery Bypass, Safety, Radial Artery